Clinical Trials Logo

Glaucoma clinical trials

View clinical trials related to Glaucoma.

Filter by:

NCT ID: NCT02614651 Completed - Glaucoma Clinical Trials

AUgmented REality for the Visually Impaired - Part 1

AUREVI 1
Start date: May 2016
Phase: N/A
Study type: Interventional

The main objective of this study is to quantify vision parameters in subjects with concentric visual field constriction, and this in relation to the display on virtual reality goggles. More specifically: - The maximum brightness value for visual comfort (THRESHOLD_MAX) - The minimum value of the perceptible light contrast in low light perceptible (THRESHOLD_MIN) - The speed of light change adaptation in the range [THRESHOLD_MAX-THRESHOLD_MIN] and [THRESHOLD_MIN-THRESHOLD_MAX].

NCT ID: NCT02613533 Completed - Glaucoma Clinical Trials

Water Drinking Test in Patients With Occludable Angle

Start date: February 2010
Phase: N/A
Study type: Interventional

The water drinking test (WDT), is a predictive test that has been used to detect primary open angle glaucoma and recently has been demonstrated as a predictor of the diurnal tension curve. Clinically accurate provocative tests for asymptomatic eyes with shallow anterior chambers and narrow angles are highly desirable to detect patients prone to angle closure glaucoma. The aim of this pilot study is to evaluate the possible role of water drinking test in patients with narrow angles who are scheduled for prophylactic laser iridotomy.

NCT ID: NCT02613442 Withdrawn - Glaucoma Clinical Trials

Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis

Start date: April 2017
Phase:
Study type: Observational

Objective: To determine the clinical variables that influence aqueous outflow facility (Co) and intraocular pressure (IOP) in uveitis. Uveitic glaucoma is potentially blinding and occurs in 17-46% of chronic uveitis patients. Uveitic activity causes fluctuating IOP due to decreased Co, increased uveoscleral outflow or decreased aqueous production. Specific Aim 1: To evaluate the risk factors for high IOP and low Co in uveitis Hypothesis: Decreased Co and increased IOP will occur with increasing anterior chamber (AC) flare, AC cells, degree of synechial angle closure, increased duration of disease, higher uveitis activity and increasing steroid use Specific Aim 2: To determine prospectively the effect of AC flare on Co and IOP in "quiescent" uveitis Hypothesis: AC flare even in the absence of AC cells will cause progressive decline in Co. Methods: In this proof of concept study, thirty consecutive patients with acute or chronic uveitis will be recruited from the uveitis clinic. Ten patients with "quiescent" uveitis (no AC cells) will be recruited for the prospective arm and followed every 2-3 months for 3 visits. Co will be measured using 2-minute pneumatonometer tonography. The effect of risk factors on IOP and Co in uveitis will be studied using generalized linear modelling techniques. These risk factors include AC flare (using the laser flare meter), AC cells, degree of angle closure (by gonioscopy), duration of disease, disease activity and corticosteroid use within the last year. In the prospective study, the patients will be divided into subgroups with low flare (< 20ph/ms) and high flare (≥ 20 ph/msec) and the change in Co and IOP will be analyzed. Impact: This will be the first study to systematically analyze the risk factors for decrease in Co and increase in IOP in uveitis and to prospectively evaluate the effect of AC flare on Co. Proof that AC flare can damage the trabecular meshwork will corroborate previous experimental evidence and change the paradigm of uveitis treatment. Knowledge of the risk factors that affect Co and IOP will aid in identifying patients that may need escalation of their uveitis or glaucoma treatment to prevent optic nerve damage.

NCT ID: NCT02613143 Recruiting - Malignant Glaucoma Clinical Trials

Zonulo-hyaloido-vitrectomy for Malignant Glaucoma

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to assess the zonulo-hyaloido-vitrectomy for malignant glaucoma through an anterior approach.

NCT ID: NCT02612571 Completed - Glaucoma Clinical Trials

Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players

Start date: July 2015
Phase: N/A
Study type: Observational

The purpose of the present study is to compare rates of glaucomatous optic neuropathy in professional wind versus non-wind instrument players in the Philadelphia Orchestra. A secondary objective is to evaluate intra-ocular pressure and choroidal thickness of wind instrument players under variable playing conditions.

NCT ID: NCT02609204 Completed - Glaucoma Clinical Trials

Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG)

DIOPSYS-ND
Start date: November 2014
Phase: N/A
Study type: Interventional

The main goal of the study is to compile a normative database for the Neuro Optic Vision Assessment (NOVATM) Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG) modules. This normalization intends to be included in a probabilistic analysis protocol to allow NOVATM PERG/FERG users to identify patients with results outside the normal ranges.

NCT ID: NCT02604953 Completed - Glaucoma Clinical Trials

Comparing SD-tVEP and PERG Tests Between Patients With Glaucoma, Patients With High Eye Pressure and "Normal" Patients

Start date: July 2014
Phase: N/A
Study type: Observational

Wills Eye Hospital Glaucoma Research Center will conduct a 1-year prospective study to assess the ability of a Short Duration Transient Visual Evoked Potential (SD- tVEP) and a Steady-State Pattern electro-retinogram (PERG) vision testing system to detect visual dysfunction in patients with ocular hypertension. The study aims to assess the reversibility of retinal ganglion cell (RGC) dysfunction after administering intraocular pressure (IOP) lowering treatment. The investigators hypothesize that SD-tVEP and PERG testing will help develop better treatment for glaucoma patients by increasing understanding of the physiological relationship of IOP and RGC in glaucomatous injury.

NCT ID: NCT02600403 Completed - Glaucoma Clinical Trials

Are There Changes in the Nerve Fiber Layer (NFL) After Lowering of Eye Pressure?

Start date: October 2011
Phase:
Study type: Observational

The aim of this study was to evaluate structural and functional improvement after lowering intraocular pressure (IOP) in patients with glaucoma using Spectral Domain Optical Coherence Tomography (SD-OCT), Visual Field (VF) testing, and Visual Evoked Potential (VEP).

NCT ID: NCT02599688 Completed - Glaucoma Clinical Trials

Open Label Extension of LipoLat-CS202

Start date: November 2015
Phase:
Study type: Observational

This is an open-label, observational extension of patients who received POLAT-001 in LipoLat-CS202.

NCT ID: NCT02598765 Recruiting - Glaucoma Clinical Trials

Micro vs. Standard Trabeculectomy Study

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the reduction in intraocular pressure and cumulative incidence of complications between the standard and micro trabeculectomy surgeries 3 months after surgery.